Clinical trials for gene therapy in lysosomal diseases with CNS involvement
C Sevin, K Deiva - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
There are over 70 known lysosomal storage disorders (LSDs), most caused by mutations in
genes encoding lysosomal hydrolases. Central nervous system involvement is a hallmark of …
genes encoding lysosomal hydrolases. Central nervous system involvement is a hallmark of …
[HTML][HTML] From Lysosomal Storage Disorders to Parkinson's Disease–Challenges and Opportunities
Lysosomes are specialized organelles with an acidic pH that act as recycling hubs for
intracellular and extracellular components. They harbour numerous different hydrolytic …
intracellular and extracellular components. They harbour numerous different hydrolytic …
Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking
Neurodegenerative disorders are characterized by a collapse in proteostasis, as shown by
the accumulation of insoluble protein aggregates in the brain. Proteostasis involves a …
the accumulation of insoluble protein aggregates in the brain. Proteostasis involves a …
Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration
S Mahali, R Martinez, M King, A Verbeck… - Translational …, 2022 - nature.com
Impaired proteostasis is associated with normal aging and is accelerated in
neurodegeneration. This impairment may lead to the accumulation of protein, which can be …
neurodegeneration. This impairment may lead to the accumulation of protein, which can be …
Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson's disease
L Francelle, JR Mazzulli - Brain research, 2022 - Elsevier
Lysosomal storage diseases (LSDs) are rare genetic disorders caused by a disruption in
cellular clearance, resulting in pathological storage of undegraded lysosomal substrates …
cellular clearance, resulting in pathological storage of undegraded lysosomal substrates …
Human iPSC-based models for the development of therapeutics targeting neurodegenerative lysosomal storage diseases
Lysosomal storage diseases (LSDs) are a group of rare genetic conditions. The absence or
deficiency of lysosomal proteins leads to excessive storage of undigested materials and …
deficiency of lysosomal proteins leads to excessive storage of undigested materials and …
Childhood dementia: A collective clinical approach to advance therapeutic development and care
JV Djafar, AM Johnson, KL Elvidge, MA Farrar - Pediatric Neurology, 2023 - Elsevier
Childhood dementias are a group of over 100 rare and ultra-rare pediatric conditions that
are clinically characterized by chronic global neurocognitive decline. This decline is …
are clinically characterized by chronic global neurocognitive decline. This decline is …
[HTML][HTML] Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue
I Stojkovska, JR Mazzulli - STAR protocols, 2021 - Elsevier
The accumulation of proteins into insoluble aggregates is a common feature of several
neurodegenerative diseases. Aggregated α-synuclein is a major component of Lewy bodies …
neurodegenerative diseases. Aggregated α-synuclein is a major component of Lewy bodies …
Neuronal and astrocytic differentiation from Sanfilippo C syndrome iPSCs for disease modeling and drug development
N Benetó, M Cozar, L Castilla-Vallmanya… - Journal of Clinical …, 2020 - mdpi.com
Sanfilippo syndrome type C (mucopolysaccharidosis IIIC) is an early-onset
neurodegenerative lysosomal storage disorder, which is currently untreatable. The vast …
neurodegenerative lysosomal storage disorder, which is currently untreatable. The vast …
Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE
J Du, F Liu, X Liu, D Zhao, D Wang, H Sun… - Journal of Translational …, 2024 - Springer
Inherited deficiency of thymidine phosphorylase (TP), encoded by TYMP, leads to a rare
disease with multiple mitochondrial DNA (mtDNA) abnormalities, mitochondrial …
disease with multiple mitochondrial DNA (mtDNA) abnormalities, mitochondrial …